U.S. Consumer Finance Stock News

Cactus (WHD) is back in focus after being highlighted as a growth stock with 21.8% one year revenue growth and solid free cash flow margins that support flexible capital deployment. Cactus shares trade at US$69.82, with the 1-day share price return of 0.43% coming after a softer patch where the 7-day and 30-day share price returns declined 3.22% and 1.76% respectively. However, the 90-day share price return of 19.21% and 1-year total shareholder return of 70.29% show momentum has been strong...

DexCom (DXCM) heads into its Wells Fargo healthcare conference appearance on 9 September with fresh attention on the stock after July’s Q2 report, when revenue rose 13.1% and shares jumped about 12%. Over the past few months, DexCom’s share price has given back some of that July excitement, with a 7 day share price return of down 6.5% and a 30 day move of down 4.3%. However, the 90 day share price return of 11.5% and year to date share price return of 26.1% point to momentum that has cooled...

Citigroup stock has delivered a very strong 3 year run while key valuation checks still suggest the shares may trade below a conservative view of intrinsic value. Recent excess returns, an undervalued read on both the Excess Returns model and market multiples, and a mixed overall value score leave investors weighing how much of the story is already reflected in today’s US$137.80 price. Over the past 3 years, Citigroup has returned about 2.6x. This puts the recent share performance firmly in...

Globus Medical stock has pulled back in recent weeks, yet over three years it has still delivered a strong gain. The current valuation checks now lean on the cheap side for a medical technology business of its size. Shares are up 51.8% over the past three years. This puts recent weakness into context as a pause after a solid multi year climb. The CE mark for the Excelsius3D imaging system in the EU and UK can support growth expectations. At the same time, execution risk around commercial...

Talen Energy filed a motion to intervene and protest at the Federal Energy Regulatory Commission against PJM’s Interim Resource Adequacy Service proposal, arguing it is unjust, unreasonable, and unduly discriminatory toward new large load customers and existing capacity resources. The protest highlights Talen Energy’s concern that excluding new large load from PJM’s capacity framework could affect competition, influence long term investment incentives for its 15.7 gigawatt fleet, and...

Medtronic stock has returned 24.7% over the past three years, yet current valuation checks suggest the shares may still trade below an estimated intrinsic value. The Discounted Cash Flow (DCF) estimate points to undervaluation of about 13.8%, while market based multiples also lean toward Medtronic being priced on the low side. The 24.7% gain over three years points to a stock that has already rewarded patient holders, but not one that shows runaway momentum. Fresh investments in Pi-Cardia...

Jefferies Financial Group stock reacts to fresh European lending push Jefferies Financial Group (JEF) is in focus after Jefferies Credit Partners outlined roughly $4 billion of lending capacity for a new European institutional direct lending strategy backed by Allianz Global Investors and other large investors. Set against this European lending push, Jefferies Financial Group shares trade at US$55.25, with the 7 day share price return up 4.44% but the year to date share price return down...

Coca-Cola stock has delivered strong gains over the past five years, while current valuation checks suggest it now trades close to a fair intrinsic value rather than at a clear discount. The market price and the Discounted Cash Flow (DCF) intrinsic value estimate are broadly aligned, even though the broader scoring framework leans on the expensive side. Over the last 5 years, Coca-Cola has returned 80.3%, which puts recent share performance firmly on the strong side of the consumer staples...

American Eagle Outfitters (NYSE:AEO) reported a strong Q2 fiscal 2026 performance, with results supported by Aerie and sizable net tariff refunds. Aerie delivered robust Q2 sales, reinforcing its role as a key growth driver within the American Eagle Outfitters portfolio. Large net tariff refunds in Q2 fiscal 2026 lifted profitability and supported higher quality margins for the period. Management raised full year fiscal 2026 operating income guidance, citing Aerie's momentum and the tariff...

PulteGroup enters this valuation check with a strong 5 year share price gain set against an intrinsic value estimate that still points to a sizeable discount, raising the question of how much of the past success is actually reflected in today's price. The stock has returned 162.2% over 5 years, which puts long term holders in a strong position even after more recent weakness. Future cash generation from PulteGroup's homebuilding pipeline can support the intrinsic value case, while any...

Ionis Pharmaceuticals stock has delivered a 51.6% gain over the past five years, yet current valuation checks flag the shares as screening on the expensive side rather than an obvious bargain. That mix of solid long term returns and a "mixed" value score puts the focus on what investors are now being asked to pay for the company’s drug portfolio and pipeline risk. The 51.6% return over five years underlines that long term holders have been rewarded, which raises the bar for what future...

Why Dollar Tree Stock Is Back In Focus Dollar Tree (DLTR) is back on investor radar after reporting second quarter earnings on August 27, 2026, that showed higher sales, revenue and net income, followed by fresh guidance and a completed multiyear buyback. Despite stronger second quarter figures and fresh guidance, Dollar Tree’s recent share price performance has cooled. The stock is down 10.25% over the past week and 8.49% over the last month, while the 1 year total shareholder return sits at...

Arm Holdings has surged year to date, yet broad valuation checks currently flag the stock as expensive rather than a clear bargain. After such a sharp move, the gap between strong recent returns and a low value score is what investors now need to size up. Arm Holdings is up 130.3% year to date, which puts extra weight on whether the current price already reflects very optimistic expectations. Excitement around Arm's role in AI chips and energy efficient processor designs can support rich...

BlackLine (BL) is back in front of institutional investors, with management scheduled to present at Citi’s 2026 Global TMT Conference in New York on September 9, putting fresh attention on the stock. Recent trading has been rough for BlackLine, with the share price down 8.42% over the past week and 45.20% year to date. The 1 year total shareholder return has declined 45.08%, suggesting fading momentum despite a modest 5.51% 90 day share price gain. Scan beyond BlackLine and see how other...

NVR stock has retreated over the past year, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiple checks still flag the shares as undervalued, while the broader valuation score suggests the overall picture is less clear cut. NVR has fallen 25.8% over the past year, which puts more focus on whether the current share price already reflects weaker sentiment toward homebuilders. The company’s integrated homebuilding model, recently highlighted in coverage of...

Pinterest stock has pulled back hard, yet on the current checks it still screens as expensive rather than a beaten down bargain. With the share price under pressure and the valuation tools pointing to a premium, investors are left weighing whether this is a value trap or an early reset. Over the past 5 years, Pinterest has delivered a share price decline of 66.3%, which signals a long stretch of weak investor returns despite the platform’s global profile. The recent announcement that CFO...

Agilent Technologies announced multiple updates, including the retirement of long-serving independent chair Koh Boon Hwee, the election of Dow R. Wilson as board chair, the appointment of former Stryker CFO Glenn Boehnlein as director, and the U.S. launch of the FDA-cleared S540MD Slide Scanner alongside the compact Cary 635 FTIR spectrometer. The combination of refreshed board oversight and new digital pathology and FTIR instruments highlights how Agilent Technologies is aligning governance...

Tsakos Energy Navigation reported second quarter 2026 net income of US$139.3 million and basic earnings per share of US$4.40, with six month net income reaching US$228.14 million and earnings per share at US$7.12, all from continuing operations. The earnings release highlights a sharp step up in profitability compared with the prior year period, referring to stronger vessel economics, firmer chartering terms, or tighter cost control across the tanker fleet as possible drivers. With Tsakos...

Constellation Brands stock has had a rough few years, yet the broader valuation checks still suggest the shares lean cheap rather than expensive. Over the past 3 years, the share price has fallen about 50%, which signals a significant reset in how the market prices Constellation Brands. The key upside driver is whether the business can sustain healthy cash generation from its core brands, while a major risk is any sustained pressure on margins that keeps profitability under strain. The stock...

Waste Management stock has delivered a solid 49.8% gain over the past five years, yet the latest intrinsic value work suggests the current share price may sit about 11% below a Discounted Cash Flow (DCF) estimate. At the same time, traditional earnings multiples screen the valuation as broadly in line with peers, which leaves investors weighing an apparent discount in the cash flow model against a market view that looks roughly fair. The 49.8% return over five years indicates Waste...

OPKO Health stock has put long term shareholders through a steep decline, with the share price down about 58.8% over five years, even as the current valuation checks suggest the shares still screen as expensive rather than a bargain. Recent shorter term gains and pullbacks leave investors weighing whether the current price already bakes in optimistic expectations for the business. The roughly 58.8% share price decline over five years points to a company that has struggled to reward patient...

Stride stock has delivered a strong 5 year gain, yet the latest valuation checks still flag it as looking cheap on broader metrics rather than fully priced in. That mix of solid long term returns and an undervalued read on the multiples is what investors in Stride now need to weigh. Over the past 5 years, Stride has returned 134.9%, which puts long term holders in a strong position even after recent volatility. The company’s focus on scalable online education can support revenue durability,...

D-Wave Quantum stock combines a very large three year gain with valuation checks that still flag the shares as expensive, which creates a tricky entry point for anyone trying to price the quantum computing story today. The share price has delivered a very large return over the past three years, which means recent buyers are paying up heavily for D-Wave Quantum compared with where it traded in 2023. Fresh CHIPS Act funding can support D-Wave Quantum's development plans, while ongoing legal...

An international tribunal recently ruled that Mexican environmental authorities unlawfully shut Vulcan Materials (VMC) quarry operations in Quintana Roo, marking a second legal win in this dispute and sharpening investor focus on the stock’s risk profile. For Vulcan Materials, the tribunal outcome lands after a weaker stretch in the market, with the share price at US$249.89 and down 3.3% over the last day, 12.4% over 30 days, and 14.6% year to date. Meanwhile, the 5 year total shareholder...